Charles River Laboratories International, Inc. (FRA:RV6)
157.65
-0.35 (-0.22%)
At close: Dec 5, 2025
FRA:RV6 Revenue
Charles River Laboratories International had revenue of $1.00B USD in the quarter ending September 27, 2025, a decrease of -0.49%. This brings the company's revenue in the last twelve months to $4.02B, down -0.92% year-over-year. In the year 2024, Charles River Laboratories International had annual revenue of $4.05B, down -1.92%.
Revenue (ttm)
$4.02B
Revenue Growth
-0.92%
P/S Ratio
2.27
Revenue / Employee
$200.18K
Employees
20,100
Market Cap
7.80B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2024 | 4.05B | -79.42M | -1.92% |
| Dec 30, 2023 | 4.13B | 153.35M | 3.86% |
| Dec 31, 2022 | 3.98B | 435.90M | 12.31% |
| Dec 25, 2021 | 3.54B | 616.23M | 21.08% |
| Dec 26, 2020 | 2.92B | 302.71M | 11.55% |
| Dec 28, 2019 | Pro | Pro | Pro |
| Dec 29, 2018 | Pro | Pro | Pro |
| Dec 30, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 26, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Rheinmetall AG | 11.00B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Deutsche Bank Aktiengesellschaft | 29.86B |
Charles River Laboratories International News
- 2 days ago - T. Rowe Price Transitions to Charles River's Enterprise Multi-Asset Investment Management Platform - Business Wire
- 3 days ago - Charles River Laboratories International, Inc. (CRL) Presents at Evercore 8th Annual Healthcare Conference Transcript - Seeking Alpha
- 3 days ago - Charles River Laboratories (CRL) Updates on Fourth-Quarter Demand Trends - GuruFocus
- 4 days ago - HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PRNewsWire
- 5 days ago - Charles River Laboratories to Present at Evercore Healthcare Conference - Wallstreet:Online
- 5 days ago - Charles River Laboratories to Present at Evercore Healthcare Conference - Business Wire
- 15 days ago - Madison Small Cap Fund Q3 2025 Portfolio Activity - Seeking Alpha
- 17 days ago - Charles River Laboratories International, Inc. (CRL) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha